Osseous differentiation of human fat tissue grafts: From tissue engineering to tissue differentiation by Bondarava, Maryna et al.
1Scientific RepoRts | 7:39712 | DOI: 10.1038/srep39712
www.nature.com/scientificreports
Osseous differentiation of 
human fat tissue grafts: From 
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Conventional bone tissue engineering approaches require isolation and in vitro propagation of 
autologous cells, followed by seeding on a variety of scaffolds. Those protracted procedures impede the 
clinical applications. Here we report the transdifferentiation of human fat tissue fragments retrieved 
from subcutaneous fat into tissue with bone characteristics in vitro without prior cell isolation and 
propagation. 3D collagen-I cultures of human fat tissue were cultivated either in growth medium or in 
osteogenic medium (OM) with or without addition of Bone Morphogenetic Proteins (BMPs) BMP-2,  
BMP-7 or BMP-9. Ca2+ depositions were observed after two weeks of osteogenic induction which 
visibly increased when either type of BMP was added. mRNA levels of alkaline phosphatase (ALP) 
and osteocalcin (OCN) increased when cultured in OM alone but addition of BMP-2, BMP-7 or BMP-9 
caused significantly higher expression levels of ALP and OCN. Immunofluorescent staining for OCN, 
osteopontin and sclerostin supported the observed real-time-PCR data. BMP-9 was the most effective 
osteogenic inducer in this system. Our findings reveal that tissue regeneration can be remarkably 
simplified by omitting prior cell isolation and propagation, therefore removing significant obstacles on 
the way to clinical applications of much needed regeneration treatments.
A growing aging population with an increased risk of bone fractures due to falls1, unfortunately often combined 
with impaired bone healing and even higher fracture risk due to osteoporosis2 and diabetes3,4, and, in addition, to 
the currently inevitable loosening of prosthetic implants over time5, urgently requires adequate bone regeneration 
strategies. The situation is exacerbated by a rising number of devastating traumatic war injuries for which often no 
other treatment option than amputation exists due to the extensive loss of bone and soft tissue6. Current treatment 
options are associated with high morbidity7–9 or deficient efficacy10. Mesenchymal stem cells (MSCs) in combina-
tion with various scaffolds are under intensive investigation and show promising achievements11–14. However, the 
involved procedure of cell isolation or separation is costly, leading to an estimated market worth 6.3 billion USD 
by 202015. Current tissue engineering strategies also involve subsequent in vitro propagation of the prior isolated 
or separated cells. These procedures add further substantial costs which is reflected in an estimated market worth 
14.8 billion USD by 201916. Extended cultivation time also holds a concerning higher risk of contamination and 
unwanted effects due to prolonged exposure to the cell culture media17. The cell propagation is currently done in 
external GMP-Facilities, which again adds costs, time and risks to the cell product. To avoid the issues afflicted 
with the use of an external GMP-Facility, the idea of a “GMP in a box”, in form of a fully automated bench-
top culture system within the primary-care facility of the patient seems very promising18. Not only would the 
use of tissue grafts instead of isolated and propagated cells clearly simplify such a system, therefore accelerating 
the availability, but because even when performed in the operating room and used autologously, cell separation is 
considered “more than minimally manipulated” by the FDA15, requiring a more rigorous approval process. Tissue 
grafts could therefore remove another obstacle on the road to a clinical application. Lastly, fat tissue grafts have 
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the potential to further the demand by surgeons for a same day, ex-vivo therapy19. For all those reasons above, it 
becomes obvious that technologies without the requirement of cell isolation and propagation would increase the 
chances to meet the need of the increasing number of patients for bone regeneration. Preclinical studies, showing 
that implantation of fat or muscle tissue fragments transduced with an adenoviral BMP-2 vector induces struc-
tural and functional healing of large segmental bone defects, were recently reported20–23. However, it remained 
unclear, whether the BMP-2 transduced tissue graft itself can undergo transdifferentiation into bone or if the graft 
rather serves as a delivery system for growth factors which stimulate and attract stem cells of the surrounding 
tissue21. If the latter would be the case, it would be advised to focus rather on drug delivery optimisation than 
cell therapies. Therefore, the aim of the present study was to investigate whether human fat tissue containing 
inhomogeneous cell populations is capable of transdifferentiation into tissue with bone characteristics. Adipose 
tissue harvest is associated with minimal donor site morbidity and it represents an especially appealing source of 
progenitor cells that can be used for the repair of bone21,24. A new culture system, introduced by Sonoda et al.25, 
represents adipose tissue fragments embedded in a three-dimensional collagen gel. This culture method was 
preferred in the present study not only because of the ability to easily entrap buoyant adipose tissue fragments, 
but also due to the support of a three-dimensional tissue structure mimicking an in vivo situation more closely 
and providing favourable conditions for cell differentiation. Bone morphogenetic proteins (BMPs) are known as 
bone forming growth factors. BMP-2 and BMP-7 have been shown to induce osteogenesis in vivo26–34, and both 
are available for clinical use35–37. Another promising growth factor inducing formation of bone is BMP-9. The 
superior potential of BMP-9 to induce osteogenic differentiation of MSCs was demonstrated both in vivo and 
in vitro38–46. However, no studies comparing the influence of BMP-2, BMP-7 and BMP-9 on human fat tissue 
fragments are available so far.
In this study, we used a modified, three-dimensional collagen I gel system to culture human subcutaneous 
fat tissue fragments in vitro. We evaluated whether cultivation with osteogenic supplements leads to tissue cal-
cification and expression of osteoblast specific protein markers. Additionally, the potential of three recombinant 
growth factors BMP-2, BMP-7 and BMP-9 to induce osteogenic transdifferentiation of fat tissue was explored 
and compared.
Results
3-Dimentional fat tissue culture system. After being embedded in collagen I gel, adipose tissue frag-
ments appeared under the phase contrast microscope as mature adipocytes attached to each other (Fig. 1A). 
After 5–7 days in culture, spindle-shaped cells were observed at the peripheral zones of the fragments migrating 
Figure 1. Phase contrast images of collagen-I fat cultures. (A) Freshly prepared culture. (B) Migration of 
spindle-shaped cells (arrows) out of the fat tissue in the collagen-I gel after 1 week of culture. (C) Migration of 
adipocytes (arrow) out of the fat tissue after 2 weeks of culture. (D) Spindle-shaped cells containing fat droplets 
(arrows) migrating into the collagen-I gel after 3 weeks of culture.
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into the collagen I gel (Fig. 1B). Furthermore, after the second week of culture, some adipocytes started to dis-
sociate from the tissue conglomerate. This could be observed exceedingly in samples cultured in normal growth 
medium (MN) (Fig. 1C). In addition to adipocytes and spindle-shaped cells, some preadipocyte-like cells with 
small fat droplets were observed in the late stages of the culture period of 4 weeks (Fig. 1D). Collagen-I gel was 
continuously shrinking during the whole period of incubation and losing its transparency under the osteogenic 
conditions. The migrating cells were spread throughout the collagen gel, partly covering the bottom surface of 
the 96-well plates.
Cell viability and proliferation. Cell viability and proliferation in the fat fragments was not only main-
tained for four weeks, but increased progressively over time in all experimental groups (Fig. 2). The highest 
WST-1 absorbance values, as an indicator of cell viability and proliferation, were observed in the osteogenic 
medium (MO) group: 0.23 ± 0.037 after 1 week, 0.64 ± 0.15 after 2 weeks, and 2.19 ± 0.36 after 4 weeks of incu-
bation. Less increase in absorbance was observed in cultures treated with normal media (MN): 0.29 ± 0.06 after 
1 week, 0.44 ± 0.12 after 2 weeks, and 1.49 ± 0.08 after 4 weeks of incubation. However, no significant difference 
was detected between the MO and MN groups. In contrast, significant lower absorbance values in compari-
son to MN were detected in all groups treated with BMPs after 4 weeks of incubation: 0.23 ± 0.04; 0.50 ± 0.12; 
0.72 ± 0.25 (p ≤ 0.05) after 1, 2 and 4 weeks respectively in the MO-BMP-2 group; 0.27 ± 0.04; 0.61 ± 0.18; 
0.76 ± 0.24 (p ≤ 0.05) after 1, 2 and 4 weeks respectively in the MO-BMP-7 group; 0.30 ± 0.07; 0.46 ± 0.09; 
0.62 ± 0.14 (p ≤ 0.01) after 1, 2 and 4 weeks respectively in the MO-BMP-9 group, indicating a significant lower 
proliferation rate in the BMP receiving groups. No significant difference between the BMP-groups was observed.
Histology. After one week of incubation, none of the five groups displayed calcium depositions. 
(Figs 3A,D,G,J,M and 4A,D,G,J,M). After the second week of incubation, the samples treated with MN showed a 
higher number of cell nuclei located between the adipocytes than compared to cultures under osteogenic condi-
tions. This suggests a higher proliferation of stromal cells in the MN group. Samples treated with MO displayed 
some regions of calcification located in the stromal cell fraction between adipocytes. The fat grafts of the BMP-2, 
-7 and -9 groups displayed a remarkable increase in extracellular calcification, as confirmed by alizarin red S as 
well as by von Kossa staining (Figs 3H,I,K,L,N,O and 4H,I,K,L,N,O). After the fourth week of incubation the 
proliferation of the stromal cells in the MN group increased even further replacing adipocytes almost completely. 
The samples treated with MO and MO + BMPs demonstrated a strong overall tissue calcification, which included 
the adjacent collagen I gel. There was no significant difference in the calcification rate observed between MO and 
MO + BMP-2, -7 or -9 experimental groups after the 4th week of incubation.
Real-time quantitative PCR (RT-PCR). Osteogenic differentiation of the 3D cultures was confirmed by 
quantitative real-time PCR measuring the expression of the early bone marker ALP and the later bone marker 
OCN mRNA. The expression of these markers in native fat tissue of each patient served as a baseline (calibrator). 
The mRNA expression of the early bone marker ALP after one week of culture was significantly (p ≤ 0.001) higher 
in samples treated with MO plus BMP-2 (2.87 ± 0.46), BMP-7 (2.78 ± 0.56) and BMP-9 (6.90 ± 2.00) compared 
to samples treated with MN (0.66 ± 0.15) or MO (0.80 ± 0.19, p ≤ 0.01 or p ≤ 0.001). The ALP-expression for MO 
plus BMP-9 was significantly higher than for all other groups (Fig. 5a). After the second week of culture the level 
of ALP in the MO + BMP-9 group was still significantly higher (4.75 ± 0.82, p ≤ 0.01) than in the other groups: 
MN (0.81 ± 0.27), MO (1.08 ± 0.28), MO + BMP-2 (1.56 ± 0.31), MO + BMP-7 (0.55 ± 0.07). However, after 
the fourth week of incubation the highest level of ALP expression was observed in the MO group (2.16 ± 0.39, 
p ≤ 0.001). The groups MO + BMP-2, MO + BMP-7 and MO + BMP-9 showed significantly higher ALP expres-
sion values (0.84 ± 0.12; 1.35 ± 0.31; 1.64 ± 0.32 respectively, p ≤ 0.05 or p ≤ 0.001) compared to the MN group 
(0.48 ± 0.14) as well (Fig. 5a).
OCN mRNA expression after the first week of culture was significantly higher in the samples treated with 
MO containing BMP-2 (0.30 ± 0.05), BMP-7 (0.40 ± 0.09) or BMP-9 (0.93 ± 0.29) than in samples treated with 
MN (0.14 ± 0.03, p ≤ 0.05) or MO (0.12 ± 0.02, p ≤ 0.01 or p ≤ 0.001) (Fig. 5b). After the second week of culture 
the level of OCN expression was significantly higher in the samples treated with MO (0.21 ± 0.03, p ≤ 0.05), 
MO + BMP-2 (0.43 ± 0.10, p ≤ 0.001), MO + BMP-7 (0.30 ± 0.06, p ≤ 0.01) and MO + BMP-9 (0.29 ± 0.04, 
p ≤ 0.001) compared to the samples treated with MN (0.11 ± 0.02). After the fourth week of incubation the 
Figure 2. WST-1 measurement of fat tissue cultures under different differentiation culture conditions. 
Values given represent means ± SE, n = 6–7. The level of significance was set as * for p < 0.05, ** for p < 0.01 and 
*** for p < 0.001.
www.nature.com/scientificreports/
4Scientific RepoRts | 7:39712 | DOI: 10.1038/srep39712
OCN mRNA was significantly overexpressed in the groups MO, MO + BMP-2, MO + BMP-7 and MO + BMP-9 
(0.60 ± 0.03, p ≤ 0.001; 0.56 ± 0.13, p ≤ 0.001; 0.47 ± 0.12, p ≤ 0.01 and 0.90 ± 0.28, p ≤ 0.001 respectively) com-
pared to to the MN group (0.14 ± 0.03) (Fig. 5b).
Immunofluorescence. Immunofluorescent staining of native fat tissue fragments for the bone markers 
osteocalcin (OCN) and osteopontin (OPN) showed that these proteins were endogenously expressed at very 
low levels in the adjacent blood vessels and in some niches of the stromal cells within fat tissue, but not in the 
adipocytes (Fig. 6A,B). In contrast, sclerostin could not be detected in native fat samples (Fig. 6C). After 4 weeks 
of culture in MN, the bone markers OCN and OPN could still be detected intracellular, although at minimal 
levels, mostly localized in the cell nuclei (Fig. 6D,E). Expression of sclerostin was not observed in MN cultures 
(Fig. 6C,F). Samples treated with MO displayed a low fluorescence signal for OCN and OPN (Fig. 6G,H) and a 
positive signal for sclerostin (Fig. 6I). All the samples treated with MO and supplemented with BMPs (BMP-2, 
BMP-7, BMP-9) showed strong fluorescence signals for OCN, OPN and sclerostin (Fig. 6J–R). There was no 
apparent difference observed concerning the expression of OCN and OPN between the three different BMPs. 
Sclerostin expression appeared to be higher in samples treated with MO + BMP-7 and MO + BMP-9 compared 
Figure 3. Histological sections of fat cultures after 1, 2 or 4 weeks under various differentiation conditions. 
Sections were stained with Alizarin red S: 1 week: (A) MN, (D) MO, (G) MO + BMP-2, (J) MO + BMP-7,  
(M) MO + BMP-9; 2 weeks: (B) MN, (E) MO, (H) MO + BMP-2, (K) MO + BMP-7, (N) MO + BMP-9; and 4 
weeks of incubation: (C) MN, (F) MO, (I) MO + BMP-2, (L) MO + BMP-7, (O) MO + BMP-9. Scale bar = 200 μm.
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to MO + BMP-2 (Fig. 6L,O,R). Furthermore, fluorescence signals from OCN, OPN and sclerostin in samples 
treated with MO + BMPs were observed not only intracellular, but also extracellular and to some extend in the 
surrounding collagen I matrix.
Discussion
In this study we employed a 3D fat tissue culture system established by Sonoda et al.25 with minor adaptations. 
Despite our adaptations, most of the vitality and histological data were in line with the results found by Sonoda 
et al.25. The fat tissue cultures in collagen I gel did not only retain their viability but rather displayed increasing 
vitality parameters over 4 weeks. The migration and proliferation of spindle-shaped cells were observed at the 
periphery of the fat tissue fragments. Cells of the same phenotype were shown by Sonoda et al. (Fig. 1B) to 
express CD 44 and CD 105 – the surface markers of mesenchymal stem cells25. Capable of migration and prolif-
eration, these cells might contribute to the osteogenic differentiation described in the present study. The dissoci-
ation of adipocytes at the late phase of the tissue culture was not shown before25. A possible reason could be the 
human origin of the tissue as opposed to the rat origin used by Sonoda and the difference in culture conditions. 
Only very few spindle-shaped cells containing lipid droplets (Fig. 1D) were observed in the cultures, making it 
Figure 4. Histological sections of fat cultures after 1, 2 or 4 weeks under various differentiation conditions. 
Sections were stained with von Kossa: 1 week: (A) MN, (D) MO, (G) MO + BMP-2, (J) MO + BMP-7,  
(M) MO + BMP-9; 2 weeks: (B) MN, (E) MO, (H) MO + BMP-2, (K) MO + BMP-7, (N) MO + BMP-9; and 4 
weeks of incubation: (C) MN, (F) MO, (I) MO + BMP-2, (L) MO + BMP-7, (O) MO + BMP-9. Scale bar = 200 μm.
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highly unlikely, that these cells are exclusively responsible for the osteogenic differentiation of the fat grafts. This 
observation rather suggests the presence of preadipocytes or dedifferentiated adipocytes within the fat tissue. 
Moreover, the vitality of the 3D cultures was continuously increasing during the first two weeks of culture with no 
significant difference between the experimental groups (Fig. 2). However, after 4 weeks of incubation the vitality 
of groups containing recombinant BMPs (BMP-2, -7 and -9) was significantly lower than in MN and MO groups. 
Addition of osteogenic growth factors to the cultures caused an accelerated differentiation rate but also a decrease 
of the proliferation rate. This was to be expected as cell differentiation has long been recognised as an opposing 
process to cell proliferation47.
Accumulation of calcium under osteogenic conditions was observed mostly among mature adipocytes at the 
sites of stromal cell localisation, or in the niches of progenitor cells (Figs 3 and 4). Presumably, only these cells pro-
duce a sufficient number of progenitors that can respond to osteogenic stimuli and differentiate into the respective 
lineage. Moreover, calcification in samples containing BMPs was observed in the collagen I gel adjacent to the fat 
tissues, suggesting the contribution of migrated cells to the overall calcification (Figs 3L,O and 4I).
Calcium accumulation during osteogenic differentiation was already described in several studies on 
adipose-derived stem cells cultured in monolayer24,48 or in 3D cultures49,50. To the best of our knowledge, this 
reported study demonstrates for the first time, osteogenic differentiation, including calcification of 3D fat tissue 
cultures of human origin in vitro. Although, Betz et al.20 have demonstrated that BMP-2 gene-activated fat tissue 
is an osteoregenerative material that has the ability to repair critical-sized bone defects in rats21, it was still unclear, 
whether the gene-activated tissues expressing BMP-2 transform into bone or solely serve as a delivery system 
for BMP-2 stimulating and attracting stem cells of the surrounding tissue. The presented data substantiates our 
hypothesis that fat tissue has the potential for the transition into bone tissue.
The RT-PCR data reveals increased mRNA expression of the bone markers ALP and OCN under osteogenic 
culture conditions. Moreover, the addition of BMP-2, -7 and -9 seems to induce osteogenesis in the fat tissue 
earlier and more intensively than osteogenic medium alone. These data were supported by the immunofluores-
cent staining for OCN, OPN and Scl. Furthermore, Scl appears to be the most specific osteogenic marker in this 
system, as it was only detectable after osteogenic stimulation but not in the native or in MN cultured tissue. The 
presented data support the hypothesis, that osteogenesis can be induced in human fat tissue without isolation 
of progenitor cells. The presence of mesenchymal stem cells and their osteogenic potential were confirmed for 
different types of adipose tissue by numerous studies48,50,51. However, no data was reported so far on fat tissue 
transdifferentiation in vitro. Limited in vivo data reporting transdifferentiation between white and brown types 
of fat cells52 as well as fat-epithelial cell differentiation53,54 was reported. Moreover, Gao et al.55 described recent 
Figure 5. Quantitative RT-PCR analysis of 3D fat cultures incubated under different differentiation 
conditions. Expression of mRNA for ALP (a) and OCN (b) normalized to mRNA levels for GAPDH. Values 
given represent means ± SE, n = 10–11. The level of significance was set as * for p < 0.05, ** for p < 0.01 and  
***for p < 0.001.
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insights in studying transdifferentiation of bone and fat related to bone metabolism. Subsequent research revealed 
the capacity of subcutaneous preadipocytes to differentiate into osteoblasts56. Other studies reported, that mature 
lipid-filled adipocytes transdifferentiated into mature osteoblasts through the preadipocytic stage with increased 
cell proliferation57,58. Also, it was discovered that single adipocytes are capable to dedifferentiate into cells with 
fibroblast-like morphology and subsequently turn into osteoblasts or adipocytes under respective stimulation58,59.
The osteogenic BMPs hold great promise for regenerative medicine60. Our results have demonstrated that 
BMP-2, -7 and -9 represent osteogenic activities and enhance osteogenic differentiation of human fat tissue 
in vitro at the mRNA and protein level. Moreover, BMP-9 seems to be a more potent osteogenic inducer for cells 
within fat tissue than BMP-2 or -7. This observation is in line with the previous studies conducting comprehen-
sive analysis of different types of human BMPs39,41,61,62. By using recombinant adenoviruses in order to facili-
tate the expression of 14 different BMPs, Luu et al., 2006 have demonstrated that, besides BMP-2 and BMP-7, 
BMP-6 and BMP-9 show the highest osteogenic activity in vitro as well as in vivo39. Li et al., 2003 have reported 
that BMP-9 displays the greatest osteogenic potential in vitro and in Sprague-Dawley rats62. Furthermore, Kang 
et al.41 suggested that high osteogenic activity of BMP-9 may be explained by transduction of a distinct osteogenic 
signalling pathway that is completely different from that of BMP-2, BMP-6 and BMP-741. One reason for the 
osteogenic potency of BMP-9 is most likely the fact, that it cannot be inhibited by noggin, an effective inhibitor 
of BMP-2 and -763,64. This would also explain why BMP-9 is involved in traumatic, heterotopic ossification where 
small amounts of BMP-9 can induce ossification of soft tissue in humans65.
In conclusion, we have demonstrated for the first time that human fat tissue is able to undergo osteogenic 
transdifferentiation under 3D culture conditions in vitro, although it remains unclear which compartments of the 
heterogenic cell population within the fat tissue are responsible for the differentiation process. We furthermore 
evaluated the osteogenic potential of human recombinant BMP-2, -7 and -9 in this system. Here, BMP-9 was 
identified to be the most potent osteogenic inducer. Our results suggest that human subcutaneous fat tissue may 
represent a regenerative material, which could be applied without cell isolation in expedited bone regeneration 
strategies21,23. Future investigations should be directed toward understanding the cellular and molecular mecha-
nisms of fat tissue transdifferentiation in vitro and in vivo and also toward the role of BMPs in this context with a 
potential focus on BMP-9.
At the clinical research front, the combinations of different BMPs and other growth factors should be evaluated 
for synergic osteogenic activity. In addition, alternative and safe BMP- delivery approaches need to be developed 
to enable efficient, safe and cost effective therapies for bone regenerative medicine.
Figure 6. Histological sections of fat cultures after 4 weeks under various differentiation conditions. 
Immunofluorescence for OCN, OPN and Scl is shown in green. Control (Ctrl) samples (A–C) represent the 
untreated fat fragments. Samples treated with MN are shown in the images (D–F); MO at (G–I); MO + BMP-2 
in (J–L); MO + BMP-7 in (M–O); MO + BMP-9 in (P–R). Nuclei of cells (blue) are shown in the corresponding 
images (A’–R’). Scale bar = 50 μ m.
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Methods
Tissue Harvest and 3-Dimentional Culture System. The tissues and data used in this study were 
provided by the Biobank (http://www.klinikum.uni-muenchen.de/Chirurgische-Klinik-und-Poliklinik-
Grosshadern/de/0800-gewebebank/index.html) located in the Hospital of the University of Munich, which oper-
ates in accordance with the European Union-compliant ethical and legal framework of the Human Tissue and 
Cell Research (HTCR) Foundation (http://www.htcr.org). The process of tissue collection included obtaining 
written informed consent from all tissue donors. The experimental procedures were performed within the frame-
work of the HTCR. This framework has also been approved by the ethics commission of the Faculty of Medicine 
in the University of Munich and the Bavarian State Medical Association66.
The subcutaneous fat tissue was obtained from 5 patients of different sex (age from 31–80, BMI 29–52). After 
rinsing with PBS containing 120 IU/ml penicillin/streptomycin and 0,375 μ g/ml amphotericin B (Biochrom, 
Germany), the adipose tissue was punched with a biopsy punch to create fragments of approximately 2 mm in 
diameter. Each fragment was then embedded in 50 μ l type I collagen gel solution (3D Collagen Culture Kit, Merck 
Millipore, Germany), which was prepared according to the manufacturer’s protocol, and placed in a 96-well tissue 
culture plate. After polymerization of the collagen, the cultures were covered either with normal, maintaining 
media (MN) (Ham’s F12/DMEM (Biochrom), 10% FCS (Sigma), 60 IU/ml penicillin/streptomycin) or osteogenic 
media (MO) (MN + 50 μ M L-ascorbic acid 2-phosphate, 10 mM β -glycerophosphate, 10 nM dexamethasone) 
alone or with addition of one of the growth factors from the BMP superfamily (100 ng/ml): rhBMP-2, rhBMP-7 
(Biomol, Germany) or rhBMP-9 (Bio-Rad, Germany). The media were changed every second day. Microscopic 
observations were performed using Axiovert 40 CFL equipped with AxioCam ERc 5 s (Carl Zeiss, Germany) after 
one day and after 1, 2 and 4 weeks of culture. Images were taken using AxioVision SE64 Rel. 4.9 software (Carl 
Zeiss, Germany). 6 cultures per one experimental group and time point were prepared and evaluated from each 
patient (90 cultures per patient).
Cell viability. Cell viability of the 3D fat cultures was determined using a water-soluble tetrasolium-1 (WST-1) 
reagent (Roche, Germany). The assay was performed after 24 hours and subsequently after 1, 2 and 4 weeks of 
culture. Briefly, the culture medium was discarded. The fresh growth medium was mixed with WST-1 at 10:1 
(v/v), added to the wells with 3D cultures or to the empty wells (blanks) and incubated for 2 hours at 37 °C in 5% 
CO2. After the incubation, 100 μ l of medium-WST-1 mixture was transferred to a 96-well culture plate and the 
absorbance was read at 450 nm using Synergy HT microplate reader and Gen 5 2.03 software (BioTek, Germany). 
The assay was repeated 7 times in the independent cultures.
Histology. Fresh fat tissue samples or 3D fat cultures were embedded in Tissue-Tek O.C.T.TM Compound 
(Sakura, Germany) and frozen immediately in liquid nitrogen. Tissue sections of 14 μ m were cut by the cryomi-
crotome (CM 3050, Leica, Germany), transferred onto SuperfrostTM Plus microscope slides (Thermo Scientific, 
USA) and air-dried. All samples were prepared in triplets.
Alizarin red S staining. Deposition of calcium in the tissue was evaluated by means of Alizarin red S staining. 
The sections were fixed with 4% Paraformaldehyde (PFA) for 15 minutes at room temperature (RT) and rinsed 
with distilled water. They were then stained with freshly prepared 40 mM alizarin red S (Sigma) solution, pH 4,1 
for 10 minutes at RT and washed in PBS. The samples were dehydrated in 100% Ethanol, cleared in Rothistol 
(Roth, Germany) and mounted with DPX (Merck).
Von Kossa staining. Slides fixed with PFA 4% and washed in distilled water were stained in 5% silver nitrate 
solution (Sigma) in the darkness for 5 minutes. They were then washed with distilled water and treated with 1% 
pyrogallic acid (Sigma) for 5 minutes. After washing and fixing with 5% NaOH for 4 minutes, the samples were 
stained with May-Grünwald stain (Sigma) for 10 minutes, dehydrated with 100% Ethanol, cleared with Rothistol 
and mounted with DPX.
RNA isolation and quantitative real-time PCR. The expression of ALP and OCN were analysed in 
combination with the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) after 1, 2 and 4 weeks of culture. 
Total mRNA was extracted using QIAzol Lysis Reagent (Qiagen, Gemany) according to manufacturer’s protocol. 
Briefly, the cultures were frozen in liquid N2 and homogenised using the Mikro-Dismembrator S (Sartorius 
Stedim Biotech, Germany). Subsequently, 1 ml QIAzol Lysis Reagent was added to the homogenate, resuspended 
and mixed with chloroform. After centrifugation, the upper aqueous phase was transferred to a new tube and 
mixed with isopropanol. The mRNA containing pellet was washed twice with 75% Ethanol, air-dried and redis-
solved in RNase-free water. After the incubation at 37 °C for 20 minutes RNA concentration and purity were 
assessed with the spectrophotometer (NanoDropTM Lite, Thermo Scientific).
cDNA synthesis was performed for 15 minutes at 42 °C using Thermocycler (T100, Bio-Rad, Germany) in a 
reaction mixture containing 300 ng total RNA, buffers, Quantiscript reverse transcriptase and RT primer mix 
from QuantiTect Reverse Transcription-Kit (Qiagen, Germany) adjusted with RNase-free water to a total volume 
of 20 μ l.
Amplification of the cDNA products was performed using the FastStart Essential DNA Green Master 
(Roche Applied Science, Germany) and the Light Cycler 96 (Roche, Germany). The reaction mixture 
contained 2,5 μ l cDNA, 300 ng primer, 5 μ l FastStart Essential DNA Green Master and RNase free water 
to a final volume of 10 μ l. Primer sequences: GAPDH forward TGCACCACCAACTGCTTAGC, reverse 
GGCATGGACTGTGGTCATGAG (annealing temperature 60 °C); ALP forward TCAAGGGTCAGCTCC 
ACCACA, reverse ATTGGCCTTCACCCCACACA (60 °C); OCN forward CCCAGGCGCTACCTGTATCAA, 
www.nature.com/scientificreports/
9Scientific RepoRts | 7:39712 | DOI: 10.1038/srep39712
reverse CTGGAGAGGAGCAGAACTGG (64 °C). Primers were obtained from Metabion (Germany). 
Amplification was performed in triplicates in 96 well plates (Roche, Germany). Relative gene expression between 
samples was calculated using the 2−ΔΔCt method, considering GAPDH as a housekeeping gene and untreated fat 
tissue as a calibrator.
Immunofluorescent staining. The tissue sections were fixed with 4% PFA and washed in PBS with 0,1% Brij 
(Sigma). Non-specific binding sites were blocked by 5% bovine serum albumin (BSA) for 30 minutes. Thereafter, 
primary antibody was added and incubated overnight. All primary antibodies (OCN, OPN, Scl) were mouse 
monoclonal IgGs from R&D Systems (Germany) used in concentrations: 25 μ g/ml (OCN, OPN) and 10 μ g/ml 
Scl. For negative controls, the first antibody was omitted. After washing off unbound antibody and permeabili-
zation with 0,1% Triton X-100 solution (Sigma) in PBS the secondary antibody goat antimouse IgG conjugated 
with Alexa Fluor 488 (Invitrogen, Germany) in the dilution 1:400 was added for 30 minutes, then intensively 
washed. Finally, the nuclei of cells were stained with Hoechst 33342 (Life Technologies, Germany). The slides 
were mounted with Fluoromount W (Serva Electrophoresis, Germany), air-dried and stored in darkness at 4 °C.
Microscopy was performed with the Zeiss Axioskop 40 equipped with appropriate filter sets and AxioCam 
MRc 5. Images were obtained with an Axio Vision, Rel. 4.9 software (Carl Zeiss, Germany).
Statistical data analysis. Data analysis was performed with Microsoft Excel 2010 and Prism 5.02 software 
for Windows. Values were presented as mean ± standard error. The Mann-Whitney U-test was used to determine 
differences between compared groups as a Gaussian distribution could not be assumed. The level of significance 
was indicated by * for p < 0.05, ** for p < 0.01 and *** for p < 0.001.
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